New evidence for the role of a specific virus causing type 1 diabetes

October 22, 2013

Type 1 diabetes is a disease caused by the destruction of the insulin-producing cells in the pancreas. It is often diagnosed in childhood and requires life-long treatment with daily insulin injections. It is associated with an increased risk for long-term complications which decrease the quality of life and average life-expectancy.

Currently around 15 million people in the world are affected by this disease, and the number of new cases is rapidly increasing. This rapid increase over the last decades indicates that environmental factors must play an important role in the disease process. Viral infections have been among one of the suspected factors, since many viruses cause in animals by damaging the insulin-producing cells in the pancreas. Some of them have also been linked to human raising the possibility of developing vaccines against these viruses to prevent some of the new cases of type 1 diabetes.

Recently, considerable progress has been made in studies evaluating the possible role of one virus group, called enteroviruses, which have been connected with human type 1 diabetes in a variety of reports.  These viruses are common in children, and more than 100 different enterovirus types have been identified in man. A subset of these enteroviruses can cause serious illnesses such as; myocarditis, meningitis, the hand-food- and -mouth disease as well as paralytic disease such as polio. Although the association between type 1 diabetes and enteroviruses has been observed in various studies, until now it was not known which enterovirus types are most responsible for this effect. 

Now, for the first time, a group of collaborating investigators have published results from two studies in the leading scientific diabetes journal Diabetes identifying the enterovirus types which are associated with type 1 diabetes. One study is based on children taking part in the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) study, which is a birth cohort study observing children at genetic risk for type 1 diabetes from birth up to or 15 years of age.

The other study (VirDiab) included children with newly diagnosed diabetes from five European countries. The results from these studies clearly show that members of the group B coxsackieviruses are associated with the risk of type 1 diabetes while the 35 other enterovirus types tested did not show such a connection.  These findings are in line with other recent reports suggesting that group B coxsackieviruses  can spread to the pancreas and damage the insulin-producing cells.

This new discovery, funded by multiple groups, opens up novel possibilities for future research aimed  at developing vaccines against these viruses to prevent type 1 diabetes. Since the group B coxsackieviruses includes only six enterovirus types it may be possible to include all of them in the same vaccine. Effective vaccines have been available for a long time against another enterovirus group, called polioviruses, which includes three enterovirus types.

There is a clear need for a diabetes vaccine since no preventive treatments are currently available for type 1 diabetes. Based on the recent findings, it is estimated that such a vaccine could have the potential for preventing a significant proportion of new cases with type 1 diabetes.  More research is needed however to confirm the causal relationship between group B coxsackieviruses and type 1 diabetes and to find out the underlying mechanisms of how these can initiate the type 1 diabetes disease process.

Explore further: Insulin 'still produced' in most people with type 1 diabetes

Related Stories

Insulin 'still produced' in most people with type 1 diabetes

October 9, 2013
New technology has enabled scientists to prove that most people with type 1 diabetes have active beta cells, the specialised insulin-making cells found in the pancreas. Type 1 diabetes occurs when the body's immune system ...

Severe hypoglycemia in diabetes tied to cardiac disease

August 16, 2013
(HealthDay)—For patients with type 1 and type 2 diabetes, severe hypoglycemia is associated with severe hypertension, hypokalemia, and QT prolongation, according to a study published online Aug. 12 in Diabetes Care.

Link between antidepressants and diabetes risk is real

September 24, 2013
Clinicians should be extra vigilant when prescribing antidepressants as they could pose a risk of type 2 diabetes, researchers at the University of Southampton have warned.

Lifestyle changes cut diabetes risk in high-risk patients

October 16, 2013
(HealthDay)—Comprehensive lifestyle interventions decrease the incidence of type 2 diabetes in high-risk patients, but the benefits are less clear in diagnosed patients, according to a review published in the Oct. 15 issue ...

Cancer prevalence higher with long duration of diabetes

January 24, 2013
(HealthDay)—Patients diagnosed with type 2 diabetes have a greater prevalence of cancer with longer diabetes duration and with insulin use, according to a study published online Jan. 8 in Diabetes Care.

Recommended for you

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

Immune system killer cells increase risk of diabetes

July 6, 2017
More than half of the German population is obese. One effect of obesity is to chronically activate the immune system, placing it under continuous stress. Researchers in Jens Brüning's team at the Max-Planck-Institute for ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.